Fact CheckerSign in

NCT06653361Completed

Ultra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation Versus Conventional Panretinal Photocoagulation in the Preservation of Visual Function and Regression of Proliferative Diabetic Retinopathy

Source: ClinicalTrials.gov · Last updated 23 Oct 2024

Brief summary (registry, in English)

Proliferative diabetic retinopathy is a vision-threatening disease that can lead to irreversible visual loss. The treatment options for proliferative diabetic retinopathy are anti-VEGF injection and retinal photocoagulation. The study aims to compare ultra-widefield fluorescein angiography-based targeted retinal photocoagulation and panretinal photocoagulation in the treatment of proliferative diabetic retinopathy.

Status (registry)
Completed
Study type
Interventional
Enrollment
120 (actual)
First submitted
20 Oct 2024
Start date
1 Sept 2022
Primary completion date
28 Feb 2024
Lead sponsor
Hayatabad Medical Complex
NCT number
NCT06653361

What you commit to

  • Study type: Interventional
  • Participants enrolled: 120
  • From 1 Sept 2022 to the primary completion date, 28 Feb 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participants with a history of previous history of:
  • vitreoretinal surgery

Other illness

  • media opacities like cataract, corneal opacity, vitreous hemorrhage

Other

  • retinal photocoagulation
  • tractional retinal detachment
  • epiretinal membrane
  • vitreomacular traction
  • glaucoma
  • uveitis
  • anti-VEGF injections in last 3 months

Who the study is looking for

  • proliferative diabetic retinopathy (PDR) with neovascularization on the disc or elsewhere in the retina

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Khyber Teaching Hospital Peshawar
Coordinator of this site? Confirm its status
PeshawarPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.